Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -5 of 5
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
6/17/2008
 
First Published:
5/23/2006
1.
Phase III Randomized Study of Doxorubicin Hydrochloride, Cyclophosphamide, Vincristine, Etoposide, and Ifosfamide With Versus Without Topotecan Hydrochloride in Patients With Newly Diagnosed Localized Ewing's Sarcoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Approved-not yet active
50 and under
NCI
COG-AEWS0531
AEWS0531, NCT00334867
Last Modified:
6/17/2008
 
First Published:
11/13/2006
2.
Phase III Randomized Study of Pegasparaginase Verus E. coli Asparaginase With Combination Chemotherapy in Children With Newly Diagnosed Acute Lymphoblastic Leukemia
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
1 to 17
NCI
DFCI-05001
NCT00400946
Last Modified:
7/24/2007
 
First Published:
1/23/2004
3.
Phase II Pilot Study of Irinotecan and Carboplatin as Upfront Window Therapy in Patients With Newly Diagnosed Intermediate- or High-Risk Rhabdomyosarcoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
30 and under at diagnosis
NCI
MSKCC-03099
NCT00077285
4.
Doxorubicin With Cisplatin, High-Dose Methotrexate, and Additional Risk-Adapted Outpatient Chemotherapy
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Treatment
Active
5 to 40
Other
2007-0404
NCT00673179
Last Modified:
10/14/2008
 
First Published:
8/26/2008
5.
Pilot Study of Zoledronic Acid in Combination With Standard Chemotherapy in Patients With Newly Diagnosed Metastatic Osteosarcoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Treatment
Active
40 and under
NCI
COG-AOST06P1
AOST06P1, NCT00742924
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute